Hunan Jiudian Pharmaceutical Co., Ltd. (300705.SZ)
CNY 17.16
(-0.12%)
CNY 17.16
(-0.12%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | 485.76 Million CNY | 14.18% |
| 2022 | 369.21 Million CNY | 22.11% |
| 2021 | 296.76 Million CNY | 104.53% |
| 2020 | 145.25 Million CNY | 46.5% |
| 2019 | 101.49 Million CNY | 0.35% |
| 2018 | 103.44 Million CNY | 9.78% |
| 2017 | 93.66 Million CNY | 25.22% |
| 2016 | 67.91 Million CNY | 22.67% |
| 2015 | 57.78 Million CNY | 9.62% |
| 2014 | 54.54 Million CNY | 63.08% |
| 2013 | 33.52 Million CNY | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q1 | 147.41 Million CNY | 132.67% |
| 2024 Q2 | 183.33 Million CNY | 34.81% |
| 2024 Q3 | 194.21 Million CNY | -2.27% |
| 2023 FY | - CNY | 14.18% |
| 2023 Q2 | 140.98 Million CNY | 61.45% |
| 2023 Q1 | 87.32 Million CNY | 20.51% |
| 2023 Q3 | 146.38 Million CNY | 3.83% |
| 2023 Q4 | 47.88 Million CNY | -67.29% |
| 2022 Q2 | 94.67 Million CNY | 36.1% |
| 2022 Q3 | 90.39 Million CNY | -4.52% |
| 2022 FY | - CNY | 22.11% |
| 2022 Q4 | 72.45 Million CNY | -19.85% |
| 2022 Q1 | 69.56 Million CNY | 22.47% |
| 2021 Q1 | 57.17 Million CNY | 53.01% |
| 2021 FY | - CNY | 104.53% |
| 2021 Q4 | 56.8 Million CNY | -16.64% |
| 2021 Q3 | 68.14 Million CNY | -15.95% |
| 2021 Q2 | 81.07 Million CNY | 41.8% |
| 2020 Q3 | 26.75 Million CNY | -19.75% |
| 2020 Q2 | 33.34 Million CNY | 263.35% |
| 2020 FY | - CNY | 46.5% |
| 2020 Q1 | 9.17 Million CNY | -54.63% |
| 2020 Q4 | 37.36 Million CNY | 39.65% |
| 2019 Q2 | 17.38 Million CNY | 37.31% |
| 2019 FY | - CNY | 0.35% |
| 2019 Q1 | 12.66 Million CNY | -58.86% |
| 2019 Q3 | 18.09 Million CNY | 4.05% |
| 2019 Q4 | 20.22 Million CNY | 11.8% |
| 2018 Q1 | 17.75 Million CNY | -30.47% |
| 2018 FY | - CNY | 9.78% |
| 2018 Q4 | 30.77 Million CNY | 66.77% |
| 2018 Q3 | 18.45 Million CNY | 15.83% |
| 2018 Q2 | 15.93 Million CNY | -10.28% |
| 2017 Q4 | 25.54 Million CNY | 3.91% |
| 2017 FY | - CNY | 25.22% |
| 2017 Q3 | 24.57 Million CNY | 43.02% |
| 2017 Q2 | 17.18 Million CNY | 49.33% |
| 2017 Q1 | 11.5 Million CNY | -61.53% |
| 2016 Q4 | 29.91 Million CNY | 129.4% |
| 2016 Q3 | 13.04 Million CNY | -1.18% |
| 2016 Q2 | 13.19 Million CNY | 60.05% |
| 2016 Q1 | 8.24 Million CNY | -37.49% |
| 2016 FY | - CNY | 22.67% |
| 2015 Q1 | 15.7 Million CNY | 21.05% |
| 2015 Q4 | 13.19 Million CNY | 0.0% |
| 2015 FY | - CNY | 9.62% |
| 2015 Q3 | 13.19 Million CNY | -16.0% |
| 2015 Q2 | 15.7 Million CNY | -0.0% |
| 2014 Q3 | 14.09 Million CNY | -13.75% |
| 2014 Q1 | 16.33 Million CNY | 0.0% |
| 2014 FY | - CNY | 63.08% |
| 2014 Q2 | 16.33 Million CNY | 0.0% |
| 2014 Q4 | 12.97 Million CNY | -7.95% |
| 2013 FY | - CNY | 0.0% |